Colorectal Cancer Clinical Trials in Phoenix, AZ

Colorectal Cancer Clinical Trials in Phoenix, AZ

View the best 10 colorectal cancer medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Colorectal Cancer clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for colorectal cancer in Phoenix, Arizona

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Leucovorin Calcium, Fluorouracil, Oxaliplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.
Image of University of California Davis in Sacramento, United States.

Tisotumab Vedotin

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted effects) may occur. There are four parts to this study.
Image of Banner MD Anderson Cancer Center in Phoenix, United States.

T3011 +1 More

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, T3011, to see if it's safe and effective in treating people with advanced solid tumors. The study will also compare T3011 given alone to T3011 given with another drug, pembrolizumab.
Image of HonorHealth Research Institute - Bisgrove in Scottsdale, United States.

Autogene Cevumeran +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial tests a personalized cancer vaccine and an immune-boosting drug in cancer patients. The vaccine teaches the body to attack cancer, while the drug helps immune cells find and kill hidden cancer cells. This approach aims to induce strong anti-tumor responses by selecting suitable vaccines based on the patient's existing immune system.
Image of Saint Joseph Heritage Medical Group in Santa Rosa, United States.

Oxaliplatin +5 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing to see if tucatinib in combination with other drugs is more effective than standard of care drugs at treating participants with HER2 positive colorectal cancer.
Image of HonorHealth Research Institute in Scottsdale, United States.

Botensilimab

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing two new drugs that help the immune system fight cancer. It targets adults with advanced cancers that haven't responded to other treatments. The drugs work by blocking proteins that usually prevent the immune system from attacking cancer cells.
Image of Alaska Oncology in Anchorage, United States.

Capecitabine +3 More

Anti-metabolites

Recruiting1 awardPhase 1 & 2
This trial studies a combo therapy for colorectal cancer, to see if it's safe and effective.
Image of Cancer Specialists of North Florida in Jacksonville, United States.

Sotorasib +1 More

Targeted Therapy

Recruiting2 awardsPhase 3
"This trial aims to see if a new treatment called sotorasib, along with panitumumab and FOLFIRI, can improve the time before the cancer progresses in patients with metast
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of City of Hope in Duarte, United States.

A2B694

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial tests a new immune cell therapy for adults with difficult-to-treat solid tumors. The therapy modifies the patient's own immune cells to target and kill cancer cells while protecting healthy cells. The study aims to find a safe dose and see how well it works.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.